Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001069698 | SCV001234886 | uncertain significance | not provided | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 698 of the ELP1 protein (p.Val698Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002497476 | SCV002806231 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030721 | SCV005021110 | uncertain significance | not specified | 2024-02-25 | criteria provided, single submitter | clinical testing | The p.V698I variant (also known as c.2092G>A), located in coding exon 18 of the IKBKAP gene, results from a G to A substitution at nucleotide position 2092. The valine at codon 698 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001828520 | SCV002082094 | uncertain significance | Familial dysautonomia | 2021-09-10 | no assertion criteria provided | clinical testing |